X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

Mississippi Supreme Court Applies AIA Subrogation Waiver to Non-Work Property Damage

In Liberty Mutual Fire Ins. Co. v. Fowlkes Plumbing., L.L.C., No. 2019-FC-10285-SCT, 2020 Miss. LEXI...

Read More >

Employment News: protected conversations, working time, investigations

It's no secret – protected conversation potentially admissible - The EAT decided in Harrison v Ary...

Read More >

Coronavirus: A Checklist for the Hospitality Industry Executive

As the Coronavirus (COVID-19) continues to disrupt travel and almost every other aspect of day-to-da...

Read More >

Healthcare Financing Trends

CBInsights recently hosted a webcast, The State of Healthcare Q2 2020. Capital raising by companies ...

Read More >

Best Practices: Protecting Your Trade Secrets in the M&A Virtual Data Room

Every day, businesses large and small are seeking to be acquired, in whole or in part. (While such e...

Read More >

Financial Daily Dose 3.26.2020 | Top Story: Senate passes $2 Trillion COVID-19 relief bill

The Senate unanimously passed a hotly anticipated third COVID-19-related stimulus bill last night, a...

Read More >